Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik Ossenkoppele

Showing results (91-100 of 310) with videos related to

Pageof 31
Sort By:
Nature Communications|November 5, 2022
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's diseaseAlexa Pichet Binette, Nicolai Franzmeier, Nicola Spotorno, et al.
Acta Neuropathologica|September 19, 2024
Association of in vivo retention of [<sup>18</sup>f] flortaucipir pet with tau neuropathology in corresponding brain regionsTove Freiburghaus, Daria Pawlik, Kevin Oliveira Hauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2021
Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development frameworkGérard N Bischof, Alessandra Dodich, Marina Boccardi, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer's Disease: A Case ReportWillem S Eikelboom, Jeroen G J van Rooij, Esther van den Berg, et al.
Neurology|December 21, 2012
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementiaRik Ossenkoppele, Wiesje M van der Flier, Marissa D Zwan, et al.
Brain : a Journal of Neurology|September 9, 2022
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individualsColin Groot, Ruben Smith, Erik Stomrud, et al.
Alzheimer'S Research & Therapy|April 5, 2022
Sex differences in neuropsychiatric symptoms in Alzheimer's disease dementia: a meta-analysisWillem S Eikelboom, Michel Pan, Rik Ossenkoppele, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsFleur H C van der Linden, Kaitlin B Casaletto, Argentina Lario Lago, et al.
Alzheimer'S Research & Therapy|November 28, 2023
Clinical outcomes up to 9 years after [<sup>18</sup>F]flutemetamol amyloid-PET in a symptomatic memory clinic populationLyduine E Collij, Gill Farrar, Marissa Zwan, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Dynamical A <i>β</i> -Tau-Neurodegeneration Model Predicts Alzheimer's Disease Mechanisms and Biomarker ProgressionPavanjit Chaggar, Jacob W Vogel, Travis B Thompson, et al.
Pageof 31

Showing results (91-100 of 310) with videos related to

Sort By:
Pageof 31
Nature Communications|November 5, 2022
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's diseaseAlexa Pichet Binette, Nicolai Franzmeier, Nicola Spotorno, et al.
Acta Neuropathologica|September 19, 2024
Association of in vivo retention of [<sup>18</sup>f] flortaucipir pet with tau neuropathology in corresponding brain regionsTove Freiburghaus, Daria Pawlik, Kevin Oliveira Hauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2021
Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development frameworkGérard N Bischof, Alessandra Dodich, Marina Boccardi, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer's Disease: A Case ReportWillem S Eikelboom, Jeroen G J van Rooij, Esther van den Berg, et al.
Neurology|December 21, 2012
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementiaRik Ossenkoppele, Wiesje M van der Flier, Marissa D Zwan, et al.
Brain : a Journal of Neurology|September 9, 2022
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individualsColin Groot, Ruben Smith, Erik Stomrud, et al.
Alzheimer'S Research & Therapy|April 5, 2022
Sex differences in neuropsychiatric symptoms in Alzheimer's disease dementia: a meta-analysisWillem S Eikelboom, Michel Pan, Rik Ossenkoppele, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsFleur H C van der Linden, Kaitlin B Casaletto, Argentina Lario Lago, et al.
Alzheimer'S Research & Therapy|November 28, 2023
Clinical outcomes up to 9 years after [<sup>18</sup>F]flutemetamol amyloid-PET in a symptomatic memory clinic populationLyduine E Collij, Gill Farrar, Marissa Zwan, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Dynamical A <i>β</i> -Tau-Neurodegeneration Model Predicts Alzheimer's Disease Mechanisms and Biomarker ProgressionPavanjit Chaggar, Jacob W Vogel, Travis B Thompson, et al.
Pageof 31